Maternal serum granulocyte colony-stimulating factor levels and spontaneous preterm birth

Journal of Women's Health

Volumn 18, Issue 1, 2009, Pages 73-78

  Whitcomb, Brian W ^a,c   Schisterman, Enrique F ^a   Luo, Xiaoping ^b   Chegini, Nasser ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MATERNAL SERUM; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; BIOLOGICAL MARKERS; BIRTH WEIGHT; DELIVERY, OBSTETRIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LOGISTIC MODELS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; SERUM; TIME FACTORS; YOUNG ADULT;

EID: 58149387617     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0883     Document Type: Article

References (32)

1. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998;339:313-320.
2. Chirico G, Ciardelli L, Cecchi P, De Amici M, Gasparoni A, Rondini G. Serum concentration of granulocyte colony-stimulating factor in term and preterm infants. Eur J Pediatr 1997;156:269-271.
3. Calhoun DA, Chegini N, Polliotti BM, Gersting JA, Miller RK, Christensen RD. Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet Gynecol 2001;97:229-234.
4. Goldenberg RL, Andrews WW, Mercer BM, et al. The preterm prediction study: Granulocyte colony-stimulating factor and spontaneous preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 2000;182:625-630.
5. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994;14:239-292.
6. Li Y, Calhoun DA, Polliotti BM, Sola MC, al Mulla Z, Christensen RD. Production of granulocyte colony-stimulating factor by the human placenta at various stages of development. Placenta 1996;17:611-617.
7. McCracken S, Layton JE, Shorter SC, Starkey PM, Barlow DH, Mardon HJ. Expression of granulocyte colony-stimulating factor and its receptor is regulated during the development of the human placenta. J Endocrinol 1996;149:249-258.
8. McCracken SA, Grant KE, MacKenzie IZ, Redman CW, Mardon HJ. Gestational regulation of granulocyte colony-stimulating factor receptor expression in the human placenta. Biol Reprod 1999;60:790-796.
9. Hardy JB. The Collaborative Perinatal Project: Lessons and legacy. Ann Epidemiol 2003;13:303-311.
10. Whitcomb BW, Schisterman EF, Klebanoff MA, Baumgarten M, Luo X, Chegini N. Circulating levels of cytokines during pregnancy: Thrombopoietin is elevated in spontaneous abortion. Fertil Steril 2007;89:1795-1805.
11. Whitcomb BW, Schisterman EF, Klebanoff MA, et al. Circulating chemokine levels and miscarriage. Am J Epidemiol 2007;166:323-331.
12. Li R, Luo X, Pan Q, et al. Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: Implication in irregular uterine bleeding. Hum Reprod 2006;21:2555-2563.
13. Beckmann I, Visser W, Struijk PC, van Dooren M, Glavimans J, Wallenburg HC. Circulating bioactive tumor necrosis factor-alpha, tumor necrosis factor-alpha receptors, fibronectin, and tumor necrosis factor-alpha inducible cell adhesion molecule VCAM-1 in uncomplicated pregnancy. Am J Obstet Gynecol 1997;177:1247-1252.
14. Weinberg CR. Toward a clearer definition of confounding. Am J Epidemiol 1993;137:1-8.
15. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-1116.
16. Greenland S. Quantifying biases in causal models: Classical confounding vs. collider-stratification bias. Epidemiology 2003;14:300-306..
17. Andrews WW, Goldenberg RL, Hauth JC. Preterm labor: Emerging role of genital tract infections. Infect Agents Dis 1995;4:196-211.
18. Goepfert AR, Jeffcoat MK, Andrews WW, et al. Periodontal disease and upper genital tract inflammation in early spontaneous preterm birth. Obstet Gynecol 2004;104:777-783.
19. Meis PJ, Goldenberg RL, Mercer B, et al. The Preterm Prediction Study: Significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1995;173:1231-1235.
20. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-493.
21. King J, Flenady V. Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 2002;CD000246.
22. McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2005;CD000262.
23. Holzman C, Lin X, Senagore P, Chung H. Histologic Chorioamnionitis and Preterm delivery. Am J Epidemiol 2007;166:786-794.
24. Elovitz MA. Anti-inflammatory interventions in pregnancy: Now and the future. Semin Fetal Neonatal Med 2006;11:327-332.
25. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M. A new model for inflammation-induced preterm birth: The role of platelet-activating factor and toll-like receptor-4. Am J Pathol 2003;163:2103-2111.
26. Andrews WW, Goldenberg RL, Hauth JC, Cliver SP, Copper R, Conner M. Interconceptional antibiotics to prevent spontaneous preterm birth: A randomized clinical trial. Am J Obstet Gynecol 2006;194:617-623.
27. Pepe MS, James H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882-890.
28. Smith SK. Angiogenesis and reproduction. Br J Obstet Gynaecol 2001;108:777-783.
29. Salafia CM, Vogel CA, Vintzileos AM, Bantham KF, Pezzullo J, Silberman L. Placental pathologic findings in preterm birth. Am J Obstet Gynecol 1991;165:934-938.
30. Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B. The relationship between placental histopathology findings and perinatal outcome in preterm infants. J Matern Fetal Neonatal Med 2003;13:102-109.
31. Goldenberg RL, Goepfert AR, Ramsey PS. Biochemical markers for the prediction of preterm birth. Am J Obstet Gynecol 2005;192:S36-S46.
32. Savitz DA, Terry JW Jr, Dole N, et al. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol 2002;187:1660-1666.